Symbol="AGIO"
AssetType="Common Stock"
Name="Agios Pharm"
Description="Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts."
CIK="1439222"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="88 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1443433000"
EBITDA="-367183008"
PERatio="None"
PEGRatio="0"
BookValue="17.3"
DividendPerShare="0"
DividendYield="0"
EPS="-3.78"
RevenuePerShareTTM="0.365"
ProfitMargin="0"
OperatingMarginTTM="-18.59"
ReturnOnAssetsTTM="-0.2"
ReturnOnEquityTTM="-0.201"
RevenueTTM="20147000"
GrossProfitTTM="12536000"
DilutedEPSTTM="-3.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.202"
AnalystTargetPrice="38.83"
TrailingPE="-"
ForwardPE="2.466"
PriceToSalesRatioTTM="164.39"
PriceToBookRatio="1.623"
EVToRevenue="107.31"
EVToEBITDA="-2.763"
Beta="0.953"
num_52WeekHigh="34.76"
num_52WeekLow="21.07"
num_50DayMovingAverage="26.78"
num_200DayMovingAverage="26.47"
SharesOutstanding="55581000"
DividendDate="None"
ExDividendDate="None"
symbol="AGIO"
open="25.66"
high="26.55"
low="25.60"
price="26.24"
volume="245109.00"
latest_trading_day="2023-08-18"
previous_close="25.97"
change="0.27"
change_percent="1.0397%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="436137"
Change_recent_avg="0.04"
Delta_recent_avg="0.94"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="144"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
